BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2171213)

  • 1. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
    Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
    Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
    Neyts J; Snoeck R; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication.
    Snoeck R; Sakuma T; De Clercq E; Rosenberg I; Holy A
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1839-44. PubMed ID: 2854454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
    Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.
    Stals FS; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro.
    Shigeta S; Konno K; Baba M; Yokota T; De Clercq E
    J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system.
    Moore MR; Hamzeh FM; Lee FE; Lietman PS
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2404-8. PubMed ID: 7840578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.
    Neyts J; Sobis H; Snoeck R; Vandeputte M; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):269-79. PubMed ID: 8390357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
    Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of experimental cytomegalovirus-induced encephalo-meningitis in immunocompromised rats with HPMPC.
    Kloover JS; Vanagt WY; Stals FS; Bruggeman CA
    Antiviral Res; 1997 Jul; 35(2):105-12. PubMed ID: 9217247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect.
    Otová B; Votruba I; Holý A
    Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
    Snoeck R; Lagneaux L; Delforge A; Bron D; Van der Auwera P; Stryckmans P; Balzarini J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):615-9. PubMed ID: 2170136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors.
    Bedard J; May S; Barbeau D; Yuen L; Rando RF; Bowlin TL
    Antiviral Res; 1999 Feb; 41(1):35-43. PubMed ID: 10321577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice.
    Neyts J; Balzarini J; Naesens L; De Clercq E
    J Med Virol; 1992 May; 37(1):67-71. PubMed ID: 1320099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotoxic potential of antiviral drugs: effects of ganciclovir and (S)-1-(3-hydroxy-2-phosphonylmethoxy propyl) cytosine on lymphocyte transformation and delayed-type hypersensitivity responses.
    Simecka JW; Patel P; Kern ER
    Antiviral Res; 1992 May; 18(1):53-64. PubMed ID: 1416903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir.
    Harada K; Eizuru Y; Isashiki Y; Ihara S; Minamishima Y
    Arch Virol; 1997; 142(2):215-25. PubMed ID: 9125039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.